Successful Management of Extensively Drug Resistant Pseudomonas aeruginosa-Infectious Scleritis after Pterygium Surgery

被引:0
|
作者
Dalal, Samruddhi [1 ]
Murthy, Somasheila, I [1 ,5 ]
Deogaokar, Ketan [1 ]
Joseph, Joveeta [2 ,3 ]
Roy, Sanhita [3 ,4 ]
机构
[1] L V Prasad Eye Inst, Cornea Inst, Cornea Serv, Hyderabad, India
[2] LV Prasad Eye Inst, Jhaveri Microbiol Ctr, Hyderabad, India
[3] LV Prasad Eye Inst, Ramoji Fdn Ctr Ocular Infect, Hyderabad, India
[4] LV Prasad Eye Inst, Hyderabad Eye Res Fdn, Brien Holden Eye Res Ctr, Hyderabad, India
[5] L V Prasad Eye Inst, Cornea Inst, Kallam Anji Reddy Campus,LV Prasad Marg,Banjara Hi, Hyderabad 500034, India
关键词
Drug-resistant Pseudomonas aeruginosa; infectious scleritis; pterygium surgery-infectious scleritis; colistin eye drops; management of Pseudomonas scleritis; BACTERIAL;
D O I
10.1080/09273948.2023.2232037
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Introduction and purposeWe report a case of extensively drug-resistant (XDR) Pseudomonas aeruginosa (PA) scleritis after pterygium surgery.MethodsCase report.ResultsA 58-year-old farmer presented with a 40-day history of severe pain, swelling, and blurred vision after a pterygium excision was performed at another institute. The patient was on multiple medications with no relief. The examination showed a nasally located scleral thinning in his right eye, with ulceration and infiltrates. Microbiology revealed Pseudomonas aeruginosa, which showed intermediate sensitivity to colistin only. The patient was administered topical (0.19%) and intravenous colistin and dexamethasone. There was a rapid reduction in symptoms, and the lesions healed over the next 2 months.ConclusionsTo the best of our knowledge, this is the first case report of XDR-PA scleritis. We suggest the possibility of evolving drug resistance caused by the iatrogenic use of antibiotics during the early stages of the disease course.
引用
收藏
页码:1279 / 1283
页数:5
相关论文
共 50 条
  • [41] Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates
    Li, Yue
    Zhu, Yiwei
    Zhou, Wanqing
    Chen, Zhongju
    Moran, Robert A.
    Ke, Huanhuan
    Feng, Yu
    van Schaik, Willem
    Shen, Han
    Ji, Jingshu
    Ruan, Zhi
    Hua, Xiaoting
    Yu, Yunsong
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (06) : 880.e1 - 880.e8
  • [42] Characterization and genetic analysis of extensively drug-resistant hospital acquired Pseudomonas aeruginosa isolates
    Abdelaziz, Mai A.
    El-Aziz, Abeer M. Abd
    El-Sokkary, Mohamed M. A.
    Barwa, Rasha
    BMC MICROBIOLOGY, 2024, 24 (01):
  • [43] Phage therapy to allow liver transplantation in a toddler infected by an extensively drug-resistant Pseudomonas aeruginosa
    Van Nieuwenhuyse, Brieuc
    Van der Linden, Dimitri
    Chatzis, Olga
    Lood, Cedric
    Wagemans, Jeroen
    Lavigne, Rob
    de Magnee, Catherine
    Sokal, Etienne
    Rodriguez-Villalobos, Hector
    Djebara, Sarah
    Merabishvili, Maya
    Soentjens, Patrick
    Pirnay, Jean-Paul
    PEDIATRIC TRANSPLANTATION, 2022, 26
  • [44] Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa
    Rodriguez-Nunez, Olga
    Ripa, Marco
    Morata, Laura
    de la Calle, Cristina
    Cardozo, Celia
    Feher, Csaba
    Pellice, Martina
    Valcarcel, Andrea
    Puerta-Alcalde, Pedro
    Marco, Francesc
    Garcia-Vidal, Carolina
    del Rio, Ana
    Soriano, Alex
    Antonio Martinez-Martinez, Jose
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 15 : 136 - 139
  • [45] Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
    Cabot, Gabriel
    Ocampo-Sosa, Alain A.
    Angeles Dominguez, M.
    Gago, Juan F.
    Juan, Carlos
    Tubau, Fe
    Rodriguez, Cristina
    Moya, Bartolome
    Pena, Carmen
    Martinez-Martinez, Luis
    Olivera, Antonio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (12) : 6349 - 6357
  • [46] In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019
    Karlowsky, James A.
    Walkty, Andrew J.
    Baxter, Melanie R.
    Adam, Heather J.
    Lagace-Wiens, Philippe R. S.
    Schweizer, Frank
    Bay, Denice
    Lynch, Joseph P., III
    Mulvey, Michael R.
    Zhanel, George G.
    MICROBIOLOGY SPECTRUM, 2022, 10 (04):
  • [47] Methyl gallate attenuates virulence and decreases antibiotic resistance in extensively drug-resistant Pseudomonas aeruginosa
    Flores-Maldonado, Orlando
    Lezcano-Dominguez, Cristina I.
    Davila-Avina, Jorge
    Gonzalez, Gloria M.
    Rios-Lopez, Ana L.
    MICROBIAL PATHOGENESIS, 2024, 194
  • [48] Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome
    Fernandes, Merle
    Vira, Divya
    Medikonda, Radhika
    Kumar, Nagendra
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (02) : 315 - 322
  • [49] Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis
    Luque-Paz, David
    Bennis, Youssef
    Jaubert, Paul
    Dubee, Vincent
    Wolff, Michel
    Mortaza, Satar
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (06) : 1787 - 1789
  • [50] Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome
    Merle Fernandes
    Divya Vira
    Radhika Medikonda
    Nagendra Kumar
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 315 - 322